NOVEL COMPOSITIONS, DEVICES, AND METHODS

FUSOGENIC LIPID NANOPARTICLES AND METHODS FOR THE MANUFACTURE AND USE THEREOF FOR THE TARGET CELL-SPECIFIC PRODUCTION OF A THERAPEUTIC PROTEIN AND FOR THE TREATMENT OF A DISEASE

GLYCEROPHOSPHOINOSITOL IN PREVENTING AND TREATING COVID-19 INFECTIONS AND METHOD FOR OBTAINING IT

PHARMACEUTICAL COMPOSITION OF RECOMBINANT ANTI-HUMAN CLDN18.2 MONOCLONAL ANTIBODY-MMAE CONJUGATE

ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF

REDUCING VISCOSITY OF PHARMACEUTICAL FORMULATIONS

GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II

ANNEXIN A1 LIQUID PHARMACEUTICAL COMPOSITION

CORONAVIRUS THERAPEUTICS AND TREATMENT METHODS

MICAFUNGIN COMPOSITIONS

MIXTURES AND FORMULATIONS COMPRISING AN ALKYL AMMONIUM EDTA SALT

STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

COMBINATION FORMULATIONS OF NALOXONE AND ATIPAMEZOLE

FORMULATION AND METHOD FOR TREATMENT OF ALZHEIMER'S DISEASE, STROKE AND DIABETIC RETINOPATHY

Extended Duration Local Anesthetic Formulation

ANTI-ARRHYTHMIC COMPOSITIONS AND METHODS

METHOD OF TREATING POST-TRAUMATIC STRESS DISORDER

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

READY-TO-INFUSE OXYTOCIN COMPOSITIONS

HYPERBRANCHED POLYGLYCEROL-COATED PARTICLES AND METHODS OF MAKING AND USING THEREOF

COMBINATION OF ANTIBODY-DRUG CONJUGATE AND IMMUNE CHECKPOINT INHIBITOR

Anti-CTLA Antibody Compositions and Related Methods

Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody

APPARATUS AND METHOD FOR PRODUCING AN ENRICHED MEDICAL SUSPENSION OF CARBON DIOXIDE

METHOD FOR TREATING CANCER BY USING ANTIBODY-DRUG CONJUGATE AND USE

STIMULI RESPONSIVE BLOCK COPOLYMERS

LIPID NANOCARRIER VACCINE

DOSAGE FORMS OF TISSUE KALLIKREIN 1

CANCER TREATMENT USING ULTRA-HIGH CONCENTRATION GASEOUS NITRIC OXIDE AND A CHECKPOINT INHIBITOR

METHODS OF TREATING MIGRAINE HEADACHE OR TENSION HEADACHE WITH HYALURONIC ACID

AMORPHOUS SOLID DISPERSIONS

METHODS FOR TREATING NEUTROPENIA

ARTESUNATE POWDERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF MANUFACTURE

PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE

Nanoparticles Containing a Taxane and their Use

Treatment Method and Product for Uterine Fibroids using Purified Collagenase

PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1-AGONIST AND METHIONINE

LIQUID FORMULATION OF IL-22R ANTIBODY

LIQUID PHARMACEUTICAL COMPOSITION

COLOR AND SYMBOL CODED DISPLAY ON A DIGITAL BADGE FOR COMMUNICATING PERMISSION TO APPROACH AND ACTIVATE FURTHER DIGITAL CONTENT INTERACTION

COMPOSITIONS AND METHODS FOR TREATING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE

COMPOSITIONS AND METHODS FOR TREATING PAIN IN SUBJECTS WITH RHEUMATOID ARTHRITIS

TREATMENT

COMPOSITIONS AND METHODS FOR CNS DISEASES

Targeting Skin-Related Conditions Using Bottlebrush Polymer-Conjugated Oligonucleotides

SURFACTANT STABILIZERS

METHODS FOR TREATING PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF

ANTIGENS FOR CANCER IMMUNOTHERAPY

Injectable Neutral pH Collagen-Based Composition For Mesotherapy

METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS

COMBINATION THERAPY FOR CLASSIC HODKIN'S LYMPHOMA

NOVEL POLYINOSINIC- POLYCYTIDYLIC ACID COMPOSITIONS

STEM CELL-DERIVED EXOSOMES FOR THE TREATMENT OF CORNEAL SCARRING

COMPOSITIONS AND METHODS FOR THE STIMULATION OF INTERMEDIATE MACROPHAGES AND TREATMENTS THEREWITH

SYSTEM AND METHOD FOR DELIVERING THERAPEUTIC AGENTS TO THE UTERINE CAVITY

EPINEPHRINE COMPOSITIONS AND CONTAINERS

RISANKIZUMAB COMPOSITIONS

PROCESS FOR FORMULATING COMPOSITIONS COMPRISING GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES

OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR

METHOD AND DEVICE FOR SUBCHONDRAL TREATMENT OF SPINE AND JOINTS

RNAS TARGETING ACTIVIN A SUBUNITS

5-HALOURACIL-MODIFIED MICRORNAS AND THEIR USE IN THE TREATMENT OF CANCER

VECTORIZED LANADELUMAB AND ADMINISTRATION THEREOF

MEDICAL USE OF CCR8 ANTIBODIES AND DOSING SCHEDULE

METHODS OF TREATING CANCER IN IMMUNOSUPPRESSED OR IMMUNOCOMPROMISED PATIENTS BY ADMINISTERING A PD-1 INHIBITOR

THERAPEUTIC COMPOUNDS

RADIOLABELED LIPOSOMES AND METHODS OF USE FOR TREATING LEPTOMENINGEAL METASTASES

PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-HER2 ANTIBODY FOR SUBCUTANEOUS ADMINISTRATION

Zonal and Targeted Methods and Uses for Treating a Chronic Post-Traumatic Headache Associated with a Post-Traumatic Stress Disorder

METHOD FOR INDUCING TISSUE REGENERATION AND TREATING AUTOIMMUNE DISEASES USING MESENCHYMAL STEM CELLS

SYNTHESIS OF 3 -RNA OLIGONUCLEOTIDES

METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS

Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure Disorders

METHODS OF DISPERSING ARIPIPRAZOLE INJECTABLE PREPARATIONS

PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION

EPINEPHRINE COMPOSITIONS AND CONTAINERS

STABLE INTRAVENOUS DILTIAZEM HYDROCHLORIDE FORMULATION AND USE THEREOF

STABLE INTRAVENOUS DILTIAZEM HYDROCHLORIDE FORMULATION AND USE THEREOF

STABLE INTRAVENOUS DILTIAZEM HYDROCHLORIDE FORMULATION AND USE THEREOF

METHODS OF MEASURING FLUORESCENCE AND CAPTURING MOVEMENT IN ANIMALS

COMPOSITIONS AND METHODS FOR TREATING WILSON'S DISEASE

AAV VECTORS ENCODING SOD1-TARGETING ARTIFICIAL MIRNAS (AMI-RNA)

METHOD OF TREATING A MAMMAL WITH DIABETES ASSOCIATED KIDNEY DISEASE USING LOCAL ADMINISTRATION OF STEM CELLS WITH TRANSIENTLY REDUCED p53

METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY

TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF Fab

SOLID FORMS AND COMBINATION COMPOSITIONS COMPRISING A BETA-LACTAMASE INHIBITOR AND USES THEREOF

SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHODS OF USE

GENE THERAPY

GANCICLOVIR COMPOSITIONS AND RELATED METHODS

METHODS OF TREATMENT FOR CERVICAL DYSTONIA

INTRAVENOUS COMPOSITIONS OF TISSUE KALLIKREIN-1 AND RELATED METHODS

COMPOSITIONS AND METHODS FOR TREATING POMPE DISEASE

SHEAR-THINNING COMPOSITIONS AS AN INTRAVASCULAR EMBOLIC AGENT

METHODS AND MATERIALS FOR TREATING OBESITY

VEGFR FUSION PROTEIN PHARMACEUTICAL COMPOSITION

TREATMENT OF IMMUNE DISORDERS

Conjugated Antisense Compounds for Use in Therapy

19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF

METHOD OF ADMINISTERING A HORMONE ENCAPSULATED BY A HYDROGEL WITH A DUAL CHAMBER SYRINGE

PROSTACYCLIN ANALOGUE FORMULATIONS

Compositions, Devices, and Methods for Treating or Preventing Headaches

PHOSPHOSERINE CONTAINING COMPOSITIONS FOR IMMUNE TOLERANCE INDUCTION

TREATMENT AND MANAGEMENT OF AUGMENTATION IN RESTLESS LEGS SYNDROME

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUNTINGTON’S DISEASE AND HTT PROTEINOPATHIES

Improved Pharmacokinetics of Tryptamine Prodrugs

DIMETHYLTRYPTAMINE AND ITS ANALOGS FOR THE PREVENTION, TREATMENT AND RECOVERY OF THE DISORDERS CAUSED BY MYOCARDIAL ISCHEMIA

CONCENTRATED SOLUTIONS COMPRISING SODIUM 5,10-METHYLENE-(6R)-TETRAHYDROFOLATE

DUAL CHAMBER SYRINGE FOR ADMINISTERING A HORMONE ENCAPSULATED BY A HYDROGEL

Facile Assembly of Soft Nanoarchitectures and Co-Loading of Hydrophilic and Hydrophobic Molecules via Flash Nanoprecipitation

HUMANIZED NON-OPIOID COMPOSITION AND THERAPIES FOR PAIN MANAGEMENT

AGONISTIC ANTI-IL-2RBG HEAVY-CHAIN ANTIBODIES

COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

RISANKIZUMAB COMPOSITIONS

MICRODYSTROPHIN GENE THERAPY ADMINISTRATION FOR TREATMENT OF DYSTROPHINOPATHIES

Pharmaceutical Compositions Having Improved Storage Stability

PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST IN AQUEOUS BLENDS OF WATER-MISCIBLE, PHARMACEUTICALLY ACCEPTABLE SOLVENTS

FUNCTIONALIZED FULLERENE GEL TUMOR TREATMENT

METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREBY

EPSTEIN-BARR VIRUS VACCINES

ANTI-GUCY2C VACCINES AND VACCINATION

Hyaluronidase Enzyme Formulations for High Volume Administration

INJECTABLE COLLAGEN MATERIAL AND PREPARATION METHOD THEREOF

INTERLEUKIN-15 SUPERAGONIST N-803 IN PEOPLE EXPERIENCING LONG COVID

Intrathecal Delivery of Recombinant Adeno-Associated Virus Encoding Methyl-CPG Binding Protein 2

METHODS FOR THE USE OF PSYCHEDELICS

METHOD FOR HYDRATING LYOPHILIZED CYCLOPHOSPHAMIDE COMPOSITION AND PRODUCT THEREOF

STABLE LIQUID COMPOSITIONS OF NETUPITANT AND PALONOSETRON

METHODS AND COMPOSITIONS FOR TREATMENT OF PAIN USING CAPSAICIN

ALLOGENEIC EXTRACELLULAR VESICLES FOR CANCER TREATMENT

PEGYLATED LIPOSOMES AND USES THEREOF

READY-TO-INFUSE PHENYLEPHRINE COMPOSITIONS

ADMINISTRATION OF A PSYCHEDELIC COMPOUND BY INTRAMUSCULAR INJECTION

TLR9-TARGETED SPHERICAL NUCLEIC ACIDS HAVING POTENT ANTITUMOR ACTIVITY

COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC HEART DISEASE

ANTIMICROBIAL PEPTIDE AND APPLICATION THEREOF

INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES

THERAPEUTIC AGENT FOR BLOOD CANCER

ACTIVATORS OF EFFECTOR T CELLS

POLYMER CONJUGATES OF DRUGS WITH CENTRAL NERVOUS SYSTEM (CNS) EFFECTS AND PERIPHERAL NMDAR BLOCKING ACTIVITY AND/OR IMMUNE SYSTEM MODULATING EFFECTS

FULVESTRANT FORMULATIONS

RE-FOCUSING PROTEIN BOOSTER IMMUNIZATION COMPOSITIONS AND METHODS OF USE THEREOF

Controlled-Release PTH Compound

METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE DAMAGE AND ARTHRITIS

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASE, CONTAINING, AS ACTIVE INGREDIENTS, CYCLODEXTRIN AND STEM CELLS IN WHICH VEGF IS OVEREXPRESSED

SODIUM BICARBONATE INJECTABLE FORMULATION AND METHODS THEREOF

METHOD FOR TREATING STRESS URINARY INCONTINENCE

POLYMER AGENTS FOR CARDIOPULMONARY RESUSCITATION

FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS

USE OF CLADRIBINE FOR TREATING AUTOIMMUNE NEUROMUSCULAR DISEASE

IP AND IP ANALOGS DOSAGE REGIMENS FOR THE TREATMENT OF ECTOPIC CALCIFICATIONS

STABLE READY TO USE CYCLOPHOSPHAMIDE LIQUID FORMULATIONS

METHOD FOR TREATING HIV WITH CABOTEGRAVIR AND RILPIVIRINE

METHOD FOR TREATING HIV WITH CABOTEGRAVIR AND RILPIVIRINE

IN SITU READY-TO-USE INJECTION FORMULATIONS OF POSACONAZOLE FREE OF CYCLODEXTRIN AND ITS DERIVATIVES

SALIVARY GLAND REGENERATION

BIOACTIVE FLUID COMPOSITIONS

COMPOSITIONS COMPRISING VANCOMYCIN

INJECTION PEN SYSTEM FOR THE DELIVERY OF AN INSULIN COMPOUND

SYNTHETIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS

PREPARATIONS CONTAINING ANTI-CLAUDIN18.2/CD3 BISPECIFIC ANTIBODY, PREPARATION METHOD THEREFOR AND USE THEREOF

POLYPEPTIDE, PREPARATION METHOD, AND USE THEREOF

POLYETHYLENE GLYCOL-MODIFIED FORM OF KININ OR DERIVATIVE THEREOF AND PHARMACEUTICAL USE THEREOF

METHODS FOR TREATMENT USING ANTI-ALPHA4BETA7 ANTIBODY

MATERIALS AND METHODS FOR REPEATABLE MAGNETIC NANOPARTICLE-BASED HEATING FOR TUMOR ABLATION

METHODS FOR PREVENTING DENGUE AND HEPATITIS A

THERAPEUTIC RNA FOR LUNG CANCER

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE VISUAL AND AUDITORY SYSTEMS

USE OF STEM CELLS EXPRESSING MESENCHYMAL AND NEURONAL MARKERS AND COMPOSITIONS THEREOF TO TREAT NEUROLOGICAL DISEASE

METHODS AND COMPOSITIONS FOR TREATING CORTICAL HYPEREXCITABILITY AND REVERSING STROKE-INDUCED CHANGES IN GENE EXPRESSION AND PROTEIN EXPRESSION

Silk-Hyaluronic Acid Compositions For Tissue Filling, Tissue Spacing, and Tissue Bulking

NOVEL DUTOGLIPTIN FORMULATIONS AND THEIR PREPARATION

Hazardous Agent Injection System

Increasing Cancer Cells' Sensitivity to Tumor Treating Fields (TTFields) by Inhibiting IL11 Activity

FORMULATIONS OF BENDAMUSTINE

BIOACTIVE FLUID COMPOSITIONS

METABOLITES FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE

Multifunctional Nanoparticles For Prevention and Treatment of Atherosclerosis

FUNCTIONALIZED POLYMERIC PARTICLES FOR TREATMENT OF GLIOMAS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

POLYMER PARTICLES FOR NEUTROPHIL INJURY

DEFORMABLE NANO-SCALE VEHICLES (DNVS) FOR TRANS-BLOOD BRAIN BARRIER, TRANS-MUCOSAL, AND TRANSDERMAL DRUG DELIVERY

Dynamically crosslinked injectable hydrogels with chemically stabilized multilamellar vesicles

USE OF ANTISENSE OLIGONUCLEOTIDE IN PREPARATION OF DRUG FOR TREATING DISEASE CAUSED BY ABNORMAL THYROID

REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB

PHARMACEUTICAL COMPOSITIONS AND DOSAGE REGIMENS FOR CLINICAL USE OF ANTI-BLOOD DENDRITIC CELL ANTIGEN 2 ANTIBODIES

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

WEARABLE DEVICE FOR RECOGNITION AND RESPONSE TO AN OVERDOSE

INJECTABLE COMPOSITION

METHODS FOR TREATMENT USING ANTI-ALPHA4BETA7 ANTIBODY

GLYCAN PROGRAMMED CELL THERAPY

USE OF GsMTx4 AND GsMTx4 CONJUGATES TO IMPROVE RECOVERY FROM JOINT INJURY

GLYCOPEPTIDE COMPOSITIONS

BIOACTIVE RENAL CELLS FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE

OXYGEN REACTIVE POLYMERS FOR TREATMENT OF TRAUMATIC BRAIN INJURY

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING OSTEOARTHRITIS

PROBENECID FOR USE IN TREATING EPILEPTIC DISEASES, DISORDERS OR CONDITIONS

MRNA DELIVERY METHOD AND COMPOSITION THEREOF

METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF LDHA

PREVENTION OF DIABETES BY ENHANCEMENT OF IMMUNE MODULATION

Pharmaceutical Composition for Preventing or Treating Sjogren's Syndrome Comprising Anti-SEMA4D Blocking Antibody as Active Ingredient

SUBCUTANEOUS ADMINISTRATION OF CD19-BINDING T CELL ENGAGERS

COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SYSTEM ATROPHY (MSA)

METHODS OF TREATMENT USING MUTANT FGF-21 PEPTIDE CONJUGATES

SYSTEMS AND METHODS FOR BOTULINUM TOXIN OR OTHER DRUG INJECTIONS FOR MEDICAL TREATMENT

VECTORS FOR DELIVERY OF HUMAN GROWTH HORMONE GENE AND MULTIPLE THERAPEUTIC GENES INTO CENTRAL NERVOUS SYSTEM BY CROSSING BLOOD BRAIN BARRIER

Replicon Compositions and Methods of Using Same for the Treatment of Diseases

Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus

ACTIVE VACCINATION FOR THE TREATMENT OF NGF-RELATED DISORDERS

COMPOSITION OF MRNA-ENCODED IL15 FUSION PROTEINS AND METHODS OF USE THEREOF

Treatment of Myasthenia Gravis with Zilucoplan

PREVENTION OF AUTOIMMUNE DIABETES

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

FUSED AMINO PYRIMIDINE COMPOUNDS FOR TREATMENT OF SEIZURE DISORDERS

METHODS OF TREATING NEUROPATHY USING FORETINIB AND COMPOSITIONS THEREOF

RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS

PEPTIDE PHARMACEUTICALS FOR TREATMENT OF NASH AND OTHER DISORDERS

SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY

MESOPOROUS SILICA NANOPARTICLES WITH LIPID BILAYER COATING FOR CARGO DELIVERY

TARGET-SPECIFIC THROMBOLYTIC UROKINASE MICROSPHERES AND METHOD TO DISSOLVE SICKLE DISEASE CLOTS

TISSUE STORAGE, IRRIGATION, AND INFUSION MEDIUM AND METHODS OF USE

METHODS OF TREATING OR PREVENTING AUTOIMMUNE DISEASES

METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER

BIODIFFUSION CHAMBER

FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTIBODY THERAPEUTICS

THERAPEUTIC ADENO-ASSOCIATED VIRUS USING CODON OPTIMIZED NUCLEIC ACID ENCODING FACTOR VIII

CO-DELIVERY OF INHIBITORY NUCLEIC ACIDS AND GENOME EDITORS FOR TUMOR THERAPY

EPHA2 ANTIBODIES

METHODS OF TREATING AXL-EXPRESSING CANCERS WITH ANTI-AXL ANTIBODIES, ANTIBODY FRAGMENTS AND THEIR IMMUNOCONJUGATES

ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN

RELEASE-CONTROLLED TOPICAL INJECTION COMPOSITION CONTAINING CYCLIC PEPTIDE AND PREPARATION METHOD THEREFOR

METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS

ORAL SURGERY DRUG

COMPOUNDS FOR TREATING TNBC

COMPOSITION FOR CANCER DIAGNOSIS TARGETING TUMOR AND/OR TUMOR MICROENVIRONMENT AND USE THEREOF

LIPID COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY

Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses

PHARMACEUTICAL COMBINATION AND USE THEREOF

THERAPEUTIC VARIANT ALPHA-2-MACROGLOBULIN COMPOSITIONS

ELIMINATION OF CD19-POSITIVE LYMPHOID MALIGNANCIES BY CD19-CAR EXPRESSING NK CELLS

PHENETHYLAMINES AND CATHINONES PRECURSORS

NUCLEIC ACID MOLECULES AND USES THEREOF FOR NON-VIRAL GENE THERAPY

UNIQUE PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR, METHODS OF USE AND PREPARATION THEREOF

PHOTODYNAMIC COMPOSITIONS AND METHODS OF USE

STABLE FORMULATIONS OF ANTI-ILT4 ANTIBODIES OR ANTIGEN-BINDING FRAGMENTS THEREROF IN COMBINATION WITH ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF

NUCLEIC ACID MOLECULES AND USES THEREOF

ENTEROCOCCUS FAECALIS VACCINE AND USES THEREOF

CTA VACCINE CASSETTES

METHODS OF AND COMPOSITIONS FOR TREATMENT OF UPPER LIMB SPASTICITY

TREATMENT AND PREVENTION OF OSTEOPOROSIS IN HIGH BODY MASS INDEX INDIVIDUALS

PTH Prodrugs

FORMULATIONS

Use of a VEGF Antagonist to Treat Angiogenic Eye Disorders

METHODS AND COMPOSITIONS FOR MODULATION OF TAU PROTEINS

BROAD-SPECTRUM PEPTOIDS FOR TREATMENT OR PREVENTION OF WOUND INFECTIONS, AND COMPOSITIONS AND METHODS OF USE THEREOF

USE OF EXTRACT FROM RABBIT SKIN INFLAMED BY VACCINIA VIRUS IN TREATMENT OF ALZHEIMER'S DISEASE

COMPOSITIONS AND METHODS FOR TREATING OSTEOARTHRITIS

BCMA/CD19 CAR FOR TREATING MULTIPLE MYELOMA

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTION AND/OR TREATMENT OF INFLAMMATION

METHODS AND COMPOSITIONS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS

METHODS AND COMPOSITIONS FOR THE TREATMENT OF DEMYELINATING DISORDERS

SUSTAINED RELEASE INJECTABLE PHARMACEUTICAL FORMULATION OF LEVOTHYROXINE AND PROCESS FOR PREPARATION THEREOF

Aqueous Quetiapine Solutions

BROAD-SPECTRUM PEPTOIDS FOR ORAL AND DENTAL HYGIENE, AND COMPOSITIONS AND METHODS OF USE THEREOF

TREATING REFRACTORY MIGRAINE

DETERMINISTIC MECHANOPORATION FOR CELL ENGINEERING

Cellular Adjuvants for Viral Infection

GLP-1R and GCGR Agonists, Formulations, and Methods of Use

DOSE REGIMEN FOR LONG-ACTING GLP1/GLUCAGON RECEPTOR AGONISTS

MODIFIED CAVEOLIN-1 PEPTIDES FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE

METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE

LOW-SORBING GLYBURIDE FORMULATION AND METHODS

COMPOSITIONS, FORMULATIONS AND METHODS FOR STIMULATING RESPIRATION

Anti-FOLR1 Immunoconjugate Dosing Regimens

ARTESUNATE POWDERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF MANUFACTURE

COMPOSITIONS AND METHODS FOR STIMULATING VENTILATORY AND/OR RESPIRATORY

Conditioning Irradiated Tissue for Increasing Vascularity

COMPOSITIONS OF KINETIC NANOPARTICLES CONTAINING NUCLEIC ACIDS, POLYCATIONS, AND LIPIDS WITH DEFINED SIZES, AND METHOD OF PRODUCING THE SAME

AQUEOUS PHARMACEUTICAL COMPOSITION OF ANTI-PD1 ANTIBODY PROLGOLIMAB AND USE THEREOF

ANTIBIOTIC FORMULATIONS FOR LOWER BACK PAIN

INJECTABLE AND INHALABLE FORMULATIONS

COMPOSITION AND METHOD FOR INHIBITING EXPRESSION OF PROTEIN LPA(APO(A))

METHODS OF TREATING BRAIN INJURY

HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

NOVEL SST4 SELECTIVE AGONISTS AS NON-OPIOID ANALGESICS

OXYSTEROLS AND METHODS OF USE THEREOF

USE OF ENDOGENOUS ASPARTOACYLASE PROMOTER ELEMENTS FOR TISSUE-RESTRICTED EXPRESSION OF GENE THERAPIES

DRUG-DELIVERY NANOPARTICLES AND TREATMENTS FOR DRUG-RESISTANT CANCER

CATIONIC BIOMATERIALS AMELIORATE OBESITY-ASSOCIATED CHRONIC INFLAMMATION AND FOCAL ADIPOSITY

HYDROGEL CROSS-LINKED HYALURONIC ACID PRODRUG COMPOSITIONS AND METHODS

CORN PHYTOGLYCOGEN FORMULATIONS FOR STABILIZING PROTEINS

RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED HA FOR REPLICATION IN EGGS

LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE

Clitoral Injection of Botulinum Toxin to Treat Sexual Dysfunction

METHODS AND COMPOSITIONS FOR INDUCING NEURAL PLASTICITY